[6] How should missed doses be handled
The protocol is a guideline, not a mandate
A Beginner's Guide to Metabolic & Hormonal Health 7 Types of Therapeutic Peptides and What Each One Does for Your Body GLP-1 Peptides Explained: How Semaglutide and Tirzepatide Are Reshaping Metabolic Medicine Peptide Therapy and Mainstream Medicine in 2026: The Evidence How to Verify Peptide Therapy Safety: Red Flags, COA Checks, and a Provider Checklist Research Peptides vs Pharmaceutical Grade: Why the Difference Could Harm You FDA July 2026 Peptide Meeting: What Patients Need to Know 8 Reasons to Get Lab Work Before Starting Any Weight Loss Program Medical Disclaimer: This article is written for educational purposes
Clinical Safety Screens Performed MTC personal AND family history in the comorbidity multi-select MEN-2 personal AND family history separately Substance / opioid screen with three-month opiate window + free-text dose, frequency, dates Suicidality and recent suicide attempt as exclusionary opt-out Active cancer treatment and cancer-free-for-five-years exclusionary End-stage kidney and liver disease opt-out Severe GI screen (gastroparesis, blockage, IBD) Pancreatitis history in the multi-select Self-reported blood pressure range and resting heart rate Past 2-month GLP-1 use (semaglutide / tirzepatide / none) No validated PHQ-2 or PHQ-9 depression instrument suicidality is captured as a binary exclusionary opt-out and severe depression is a checkbox on the comorbidity multi-select, but the validated brief screening scale is not used
Many peptides circulating online are not approved for therapeutic use and are not listed in the Poisons Standard, meaning they cannot legally be supplied, manufactured or imported for human use
